Home > Products > Tumor Cell Lines > Human Tumor Cell Lines >
DMS 153 |
||||
---|---|---|---|---|
Product Name |
DMS 153 |
|||
Price | Get Quote | |||
Product Code | DMS-153; DMS153 |
|||
Cat.No |
ABC-TC0213 |
Species |
Human |
|
Size/Quantity |
1 vial |
Biosafety Level |
1 |
|
Shipping Info |
Dry Ice |
Storage |
Liquid Nitrogen |
|
Description |
Why choose DMS 153 from AcceGen? AcceGen’s DMS 153 cell line stands out for its robust features, boasting high viability and top-notch quality. These cells are carefully nurtured under ideal conditions and expertly cryopreserved. They are delivered in a sterile state, thoroughly screened to be mycoplasma-free, and their identity is confirmed through STR analysis, all part of AcceGen’s stringent quality control measures, making them a trusted and reliable choice for research applications. |
|||
Disease | Lung Small Cell Cancer |
|||
Source Organ | Lung |
|||
Recommended Medium And Supplement | Waymouth’s MB 752/1 + 2mM Glutamine + 10% FBS |
|||
Citation Guide |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). |
|||
Application | FOR RESEARCH USE ONLY The DMS 153 cell line plays a pivotal role in cancer research, particularly in the study of small cell carcinoma of the lung (SCLC). Researchers utilize this cell line to identify novel biomarkers that can aid in the diagnosis and treatment of SCLC. Additionally, DMS 153 cells are instrumental in elucidating the effects of potential therapeutic strategies on cancer cells, including the induction of apoptosis, offering valuable insights into the development of more effective treatments for this aggressive form of lung cancer. |
|||
Growth Conditions | 37 ℃, 5% CO2 |
|||
Growth Mode | Semi-adherent |
|||
Product Type |
Human Lung Cancer Cell Lines |
|||
Product Image |
![]() |
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.